These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34315233)

  • 1. Trends in Use of Cardioprotective Medication in Peripheral Artery Disease: A Nationwide Study.
    Kamil S; Sehested TSG; Houlind K; Lassen JF; Gislason GH; Dominguez H
    J Am Heart Assoc; 2021 Aug; 10(15):e020333. PubMed ID: 34315233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
    Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends in the risk of atrial fibrillation and ischaemic stroke in patients with peripheral artery disease between 1997 and 2015.
    Kamil S; Sehested T; Houlind K; Lassen J; Gislason G; Dominguez H
    Open Heart; 2020 Apr; 7(1):. PubMed ID: 32354739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Søgaard M; Nielsen PB; Skjøth F; Eldrup N; Larsen TB
    Circulation; 2021 Mar; 143(9):907-920. PubMed ID: 33300375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.
    Kugathasan P; Horsdal HT; Aagaard J; Jensen SE; Laursen TM; Nielsen RE
    JAMA Psychiatry; 2018 Dec; 75(12):1234-1240. PubMed ID: 30422158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
    Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Otero García D; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    Eur J Clin Invest; 2021 Apr; 51(4):e13431. PubMed ID: 33065765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological Trends and Projections of Incidence, Prevalence, and Disease Related Mortality Associated With Peripheral Arterial Disease: Observations Using Nationwide Danish Data.
    Søgaard M; Nielsen PB; Eldrup N; Behrendt CA; Nicolajsen CW; Lip GYH; Skjøth F
    Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):662-669. PubMed ID: 37567342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry.
    Subherwal S; Patel MR; Tang F; Smolderen KG; Jones WS; Tsai TT; Ting HH; Bhatt DL; Spertus JA; Chan PS
    J Am Coll Cardiol; 2013 Jul; 62(1):51-7. PubMed ID: 23643497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system.
    Reynolds K; Mues KE; Harrison TN; Qian L; Chen S; Hsu JY; Philip KJ; Monda KL; Reading SR; Brar SS
    Vasc Med; 2020 Feb; 25(1):3-12. PubMed ID: 31512991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke in Patients With Peripheral Artery Disease.
    Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
    Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
    Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underuse of Cardiovascular Medications in Individuals With Known Lower Extremity Peripheral Artery Disease: HCHS/SOL.
    Hua S; Isasi CR; Kizer JR; Matsushita K; Allison MA; Tarraf W; Qi Q; Ponce SG; Daviglus M; Kaplan RC
    J Am Heart Assoc; 2020 Aug; 9(16):e015451. PubMed ID: 32752978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.